• Je něco špatně v tomto záznamu ?

Live-Cell High Content Screening in Drug Development

M. Esner, F. Meyenhofer, M. Bickle,

. 2018 ; 1683 (-) : 149-164.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18024523

In the past decade, automated microscopy has become an important tool for the drug discovery and development process. The establishment of imaging modalities as screening tools depended on technological breakthroughs in the domain of automated microscopy and automated image analysis. These types of assays are often referred to as high content screening or high content analysis (HCS/HCA). The driving force to adopt imaging for drug development is the quantity and quality of cellular information that can be collected and the enhanced physiological relevance of cellular screening compared to biochemical screening. Most imaging in drug development is performed on fixed cells as this allows uncoupling the preparation of the cells from the acquisition of the images. Live-cell imaging is technically challenging, but is very useful for many aspects of the drug development pipeline such as kinetic studies of compound mode of action or to analyze the motion of cellular components. Most vendors of HCS microscopy systems offer the option of environmental chambers and onboard pipetting on their platforms. This reflects the wish and desire of many customers to have the ability to perform live-cell assays on their HCS automated microscopes. This book chapter summarizes the challenges and advantages of live-cell imaging in drug discovery. Examples of applications are presented and the motivation to perform these assays in kinetic mode is discussed.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024523
003      
CZ-PrNML
005      
20180710092724.0
007      
ta
008      
180709s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/978-1-4939-7357-6_10 $2 doi
035    __
$a (PubMed)29082492
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Esner, Milan $u High Throughput Technology Development Studio (HT-TDS), Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstrasse 108, 01307, Dresden, Germany. Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 3, 625 00, Brno, Czech Republic.
245    10
$a Live-Cell High Content Screening in Drug Development / $c M. Esner, F. Meyenhofer, M. Bickle,
520    9_
$a In the past decade, automated microscopy has become an important tool for the drug discovery and development process. The establishment of imaging modalities as screening tools depended on technological breakthroughs in the domain of automated microscopy and automated image analysis. These types of assays are often referred to as high content screening or high content analysis (HCS/HCA). The driving force to adopt imaging for drug development is the quantity and quality of cellular information that can be collected and the enhanced physiological relevance of cellular screening compared to biochemical screening. Most imaging in drug development is performed on fixed cells as this allows uncoupling the preparation of the cells from the acquisition of the images. Live-cell imaging is technically challenging, but is very useful for many aspects of the drug development pipeline such as kinetic studies of compound mode of action or to analyze the motion of cellular components. Most vendors of HCS microscopy systems offer the option of environmental chambers and onboard pipetting on their platforms. This reflects the wish and desire of many customers to have the ability to perform live-cell assays on their HCS automated microscopes. This book chapter summarizes the challenges and advantages of live-cell imaging in drug discovery. Examples of applications are presented and the motivation to perform these assays in kinetic mode is discussed.
650    _2
$a zvířata $7 D000818
650    _2
$a buněčné kultury $7 D018929
650    _2
$a kultivované buňky $7 D002478
650    12
$a objevování léků $x metody $7 D055808
650    12
$a rychlé screeningové testy $7 D057166
650    _2
$a lidé $7 D006801
650    _2
$a počítačové zpracování obrazu $7 D007091
650    _2
$a mikroskopie $7 D008853
650    _2
$a molekulární zobrazování $x metody $7 D057054
650    _2
$a software $7 D012984
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Meyenhofer, Felix $u High Throughput Technology Development Studio (HT-TDS), Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstrasse 108, 01307, Dresden, Germany. Département de Médecine, Faculté des Sciences, University of Fribourg, 1, Rte., Albert Gockel, Fribourg, 1700, Switzerland.
700    1_
$a Bickle, Marc $u High Throughput Technology Development Studio (HT-TDS), Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstrasse 108, 01307, Dresden, Germany. bickle@mpi-cbg.de.
773    0_
$w MED00180389 $t Methods in molecular biology (Clifton, N.J.) $x 1940-6029 $g Roč. 1683, č. - (2018), s. 149-164
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29082492 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180710093014 $b ABA008
999    __
$a ok $b bmc $g 1316654 $s 1021444
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 1683 $c - $d 149-164 $i 1940-6029 $m Methods in molecular biology $n Methods Mol Biol $x MED00180389
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...